Schizophrenia Research

Schizophrenia is a chronic, debilitating mental disorder affecting 1-2% of the global population. Symptoms are split into two types; 'positive' symptoms, including delusions and hallucinations, and 'negative' symptoms, including anhedonia and lack of motivation. Studies suggest that genetics, early environment, neurobiology, psychological and social processes are important contributory factors; some recreational and prescription drugs appear to cause or worsen symptoms. Several neurobiological alterations in brain structure, physiology and neurochemistry have been documented, along with an ever-increasing list of susceptibility genes.

Schizophrenia Research Products Targets

Products for Schizophrenia Research - Page 22

  1. Cat.No. Product Name Information/Activity
  2. BCC5972 PHA 543613 hydrochloride 478149-53-0 PHA 543613 hydrochloride chemical structure
  3. BCC7574 PHA 568487 527680-57-5 PHA 568487 chemical structure
  4. BCC7700 S 24795 304679-75-2 S 24795 chemical structure
  5. BCC7394 TC 1698 dihydrochloride 787587-06-8 TC 1698 dihydrochloride chemical structure
  6. BCC7264 α-Bungarotoxin 11032-79-4 α-Bungarotoxin chemical structure
  7. BCC1047 COG 133 ApoE peptide fragment; <span class='symbol'>&#945;</span>7 nAChR antagonist COG 133 chemical structure
  8. BCC5974 α-Conotoxin ImI 156467-85-5 α-Conotoxin ImI chemical structure
  9. BCC6897 Methyllycaconitine citrate 112825-05-5 Methyllycaconitine citrate chemical structure
  10. BCC7028 MG 624 77257-42-2 MG 624 chemical structure
  11. BCC4027 Tropisetron Hydrochloride Tropisetron Hydrochloride (SDZ-ICS-930) is a selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist with an IC50 of 70.1 ± 0.9 nM for 5-HT3 receptor. Tropisetron Hydrochloride chemical structure

Items 211 to 220 of 709 total